Jones Financial Companies
IMRX icon

Jones Financial Companies’s Immuneering IMRX Stock Holding History

Jones Financial Companies’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149 Hold
30
– – ﹤0.01% 4615
2025
Q4 		$197 Buy
+30
New +$193 ﹤0.01% 4270

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jones Financial Companies's IMRX Position: Q1 2026 in Review

Jones Financial Companies held its Immuneering (IMRX) position steady in Q1 2026 at 30 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #4615.

Jones Financial Companies first reported a position in IMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $197 in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Jones Financial Companies held 30 shares of Immuneering worth $149 as of Q1 2026.
  • Jones Financial Companies left its Immuneering share count unchanged in Q1 2026.
  • Immuneering made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4615 holding.
  • Jones Financial Companies first reported a position in Immuneering in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's Immuneering position peaked at $197 in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.